14 Best Biotech Stocks to Buy Right Now

Page 14 of 14

1. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Number of Hedge Fund Holders: 73

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ranks among the best biotech stocks to buy. On September 17, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) revealed the findings of its Phase 2 COURAGE trial, which demonstrated that semaglutide and trevogrumab together preserved lean muscle mass while treating obesity with weight loss.

According to the 26-week trial, semaglutide by itself resulted in a 33% of weight loss to come from lean mass loss. In patients treated with semaglutide, around half of the muscle mass that would have been lost was preserved when trevogrumab, an anti-GDF8/anti-myostatin antibody, was introduced.

The study’s weight-loss phase results were reported at the European Association for the Study of Diabetes meeting. In the meantime, patients will continue in a weight maintenance phase through week 52.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a prominent biopharmaceutical company that discovers, develops, and commercializes medicines for a variety of diseases, including cancer, eye disorders, and allergies.

While we acknowledge the potential of REGN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than REGN and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 14 of 14